Tus-Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 76.738 million compared to CNY 60.492 million a year ago. Operating income was CNY 21.543 million compared to CNY 9.315 million a year ago. Net income was CNY 20.462 million compared to CNY 8.881 million a year ago. Basic earnings per share from continuing operations was CNY 0.0854 compared to CNY 0.0371 a year ago.